Effects of weight loss on testosterone, sex hormone‐binding globulin, adiposity, and insulin sensitivity in women and men
Obesity · 2025
DOI: 10.1002/oby.24269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2025. Verfasst von Justine M Mucinski und 3 weiteren Autor:innen. Beteiligte Einrichtung: AdventHealth Translational Research Institute, AdventHealth Orlando, Orlando, Florida, USA. Hauptthemen laut MEDLINE: Sex Hormone-Binding Globulin, Testosterone, Weight Loss, Obesity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Objective
Testosterone and glucose disposal (Rd) are positively associated in adult men, whereas the opposite is reported in women. Sex‐specific relationships between testosterone or sex hormone‐binding globulin (SHBG) and Rd in men and women with and without obesity and following weight loss were examined.
Methods
Adult men and women ( n = 27/28; BMI = 20–41 kg/m 2 ) underwent measurements of body composition, Rd, SHBG, and bioavailable (BioA) and total testosterone. Men and women ( n = 17/15) with obesity completed a 16‐week dietary weight‐loss program with repeat testing.
Results
BioA testosterone was lower in men with obesity and was related to Rd positively in men and negatively in women ( p < 0.05). Across participants, weight loss increased Rd and SHBG ( p < 0.01). BioA testosterone was unchanged in men; however, individual changes were independently related to Rd ( p = 0.031). In women, BioA testosterone declined ( p < 0.009) but was not related to Rd.
Conclusions
BioA testosterone was associated with Rd, positively in men and negatively in women. Weight loss reduced BioA testosterone in women; however, individual changes were associated with improved Rd in men. SHBG was a better correlate of improved Rd in women. Additional studies should identify mechanisms that drive sex differences and interventions that modify testosterone, reduce adiposity, and improve Rd across both sexes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- AdventHealth Translational Research Institute, AdventHealth Orlando, Orlando, Florida, USA.
- Merck & Co. Inc., Kenilworth, New Jersey, USA.
- Division of Endocrinology, Metabolism and Diabetes, University of Louisville, Louisville, Kentucky, USA.
ORCID-Profile: Justine M Mucinski
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Mucinski, J. M., Kelley, D. E., Winters, S. J., & Goodpaster, B. H. (2025). Effects of weight loss on testosterone, sex hormone‐binding globulin, adiposity, and insulin sensitivity in women and men. Obesity. https://doi.org/10.1002/oby.24269
Vancouver
Mucinski JM, Kelley DE, Winters SJ, Goodpaster BH. Effects of weight loss on testosterone, sex hormone‐binding globulin, adiposity, and insulin sensitivity in women and men. Obesity. 2025. doi:10.1002/oby.24269
BibTeX
@article{Mucinski2025,
author = {Mucinski, Justine M and Kelley, David E and Winters, Stephen J and Goodpaster, Bret H},
title = {Effects of weight loss on testosterone, sex hormone‐binding globulin, adiposity, and insulin sensitivity in women and men},
journal = {Obesity},
year = {2025},
doi = {10.1002/oby.24269}
}
EUVIMED